WebDec 5, 2024 · Sonothera closes $60M series A round to advance gene therapy platform. Dec. 5, 2024. By Meg Bryant. Sonothera Inc. reeled in $60.75 million in a series A financing led … WebSonoThera™, a biotechnology company dedicated to treating the root cause of human diseases through genetic therapy, today announced it has received exclusive, global, …
SonoThera inks licensing deal with GE HealthCare
WebDec 5, 2024 · SonoThera is a biotechnology company that creates non-viral genetic therapies using ultrasound. Its mission is to develop genetic medicines that treat the root … WebMay 2024. Ivan Krivega. Ann Dean. Mechanistic studies in erythroid cells indicate that LDB1, as part of a GATA1/TAL1/LMO2 complex, brings erythroid-expressed genes into proximity … chisorb 944
SonoThera™ Receives Exclusive Licensing of GE HealthCare’s …
WebDec 12, 2024 · The Life Sciences team advised SonoThera, Inc. in its $60.75 million Series A financing round to support the continued development of SonoThera’s ultrasound-guided, … WebDec 12, 2024 · SonoThera is developing an ultrasound-guided, nonviral gene therapy platform and treatments designed to provide patients with the next generation of safe and … WebDec 5, 2024 · SonoThera raised $60750000 on 2024-12-05 in Series A. ARCH Venture Partners ARCH is an early-stage venture firm that focuses on life science discoveries to … graphpad readout